scPharmaceuticals Inc. provided revenue guidance for the full year 2023. For the period, the company anticipates net revenue to be in a range of $13.4 million to $13.6 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 USD | +0.66% | +5.29% | -26.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.95% | 164M | |
+30.91% | 699B | |
+25.07% | 571B | |
-4.60% | 364B | |
+18.23% | 326B | |
+2.79% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-4.45% | 154B |
- Stock Market
- Equities
- SCPH Stock
- News scPharmaceuticals Inc.
- ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023